iKang Healthcare Group, Inc.
KANG
KANG was delisted on the 18th of January, 2019.
59 hedge funds and large institutions have $369M invested in iKang Healthcare Group, Inc. in 2017 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 18 increasing their positions, 19 reducing their positions, and 3 closing their positions.
233% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 3
133% more funds holding in top 10
Funds holding in top 10: 3 → 7 (+4)
23% more capital invested
Capital invested by funds: $299M → $369M (+$70.1M)
13% more funds holding
Funds holding: 52 → 59 (+7)
5% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 19
98% less call options, than puts
Call options by funds: $501K | Put options by funds: $22M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FI
Fosun International
Hong Kong,
China
|
+$15M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$8.99M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.59M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$2.98M |
| 5 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
+$1.86M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
QF
QVT Financial
New York
|
-$7.94M |
| 2 |
Walleye Trading
New York
|
-$7.81M |
| 3 |
First Manhattan
New York
|
-$6.44M |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
-$4.53M |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$3.56M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
51
Tower Research Capital (TRC)
New York
| $46K | +$42.3K | +2,931 | New |
|
52
UBS Group
Zurich,
Switzerland
| $21K | +$5.72K | +396 | +41% |
|
|
PA
53
Parallel Advisors
San Francisco,
California
| $13K | – | – | – |
|
|
GXMC
54
Global X Management Company
New York
| $8K | – | – | – |
|
|
55
Walleye Trading
New York
| $4.33K | -$7.81M | -540,258 | -66% |
|
56
US Bancorp
Minneapolis,
Minnesota
| $2K | – | – | – |
|
|
TDC
57
Thompson Davis & Co
Richmond,
Virginia
| $2K | +$1.81K | +125 | New |
|
58
BNP Paribas Financial Markets
Paris,
France
| $79 | – | – | – |
|
59
Citadel Advisors
Miami,
Florida
| – | -$345K | -23,854 | Closed |
|
|
PCM
60
Prelude Capital Management
New York
| – | -$263K | -19,500 | Closed |
|
|
CG
61
Cutler Group
San Francisco,
California
| – | -$6K | -493 | Closed |
|
62
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$116 | -8 | -57% |
|
KANG Hedge Fund Activity: Q4 2017 in Review
59 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in iKang Healthcare Group, Inc. (KANG) for Q4 2017, worth a combined $369M — up 23% from $299M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new KANG positions and 3 closed out — a net gain of 7 holders — while 18 added to existing stakes and 19 trimmed.
The largest buyer was Fosun International, adding an estimated $15M. The largest seller was QVT Financial, cutting an estimated $7.94M.
- 59 institutional investors held iKang Healthcare Group, Inc. (KANG) as of Q4 2017, up from 52 in Q3 2017.
- Funds reported $369M of iKang Healthcare Group, Inc. stock for Q4 2017, up 23% quarter-over-quarter.
- 10 funds opened new iKang Healthcare Group, Inc. positions in Q4 2017 and 3 closed out, a net change of +7 holders.
- The largest iKang Healthcare Group, Inc. buyer in Q4 2017 was Fosun International, an estimated $15M added.
- The largest iKang Healthcare Group, Inc. seller in Q4 2017 was QVT Financial, an estimated $7.94M sold.
Based on aggregated 13F filings for Q4 2017.